An analysis published in the Lancet that concluded the flu drug Tamiflu (osteltamivir) is effective after all has been slammed by a Cochrane reviewer. The review which looked at 9 studies found the drug reduced flu symptoms by about a day, compared to placebo. It reduced the risk of lower respiratory tract infections requiring antibiotics by 44% ...
Already a member?
Enter your email to keep reading.